|
COPS3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.31289999982798E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.20940000014613E-07 |
| Normal-vs-Stage2 |
2.614800E-01 |
| Normal-vs-Stage3 |
2.207899996165E-08 |
| Normal-vs-Stage4 |
6.33529895210927E-11 |
| Stage1-vs-Stage2 |
6.519500E-03 |
| Stage1-vs-Stage3 |
1.326990E-01 |
| Stage1-vs-Stage4 |
2.615100E-03 |
| Stage2-vs-Stage3 |
2.016300E-03 |
| Stage2-vs-Stage4 |
3.97880000000406E-05 |
| Stage3-vs-Stage4 |
6.714500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.43820013862739E-10 |
| Normal-vs-AfricanAmerican |
2.116200E-02 |
| Normal-vs-Asian |
1.96062999999747E-05 |
| Caucasian-vs-AfricanAmerican |
4.669600E-01 |
| Caucasian-vs-Asian |
7.206200E-01 |
| AfricanAmerican-vs-Asian |
7.020400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.08590000325037E-08 |
| Normal-vs-Female |
1.11930000046279E-07 |
| Male-vs-Female |
1.330210E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.17710000039295E-07 |
| Normal-vs-Age(41-60Yrs) |
1.73049996554653E-09 |
| Normal-vs-Age(61-80Yrs) |
9.66580000000272E-05 |
| Normal-vs-Age(81-100Yrs) |
2.722300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.932590E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.847200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.930800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.374200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.762400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.404400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.704400E-02 |
| Classical-VS-Follicular |
6.821400E-04 |
| Classical-VS-Other |
3.247200E-01 |
| Classical-VS-Normal |
1.46799999933833E-08 |
| Tall-VS-Follicular |
1.74732000000066E-05 |
| Tall-VS-Other |
9.374200E-01 |
| Tall-VS-Normal |
2.38599995316946E-09 |
| Follicular-VS-Other |
8.274100E-02 |
| Follicular-VS-Normal |
1.617160E-01 |
| Other-VS-Normal |
8.814800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.05219999999118E-05 |
| Normal-vs-N1 |
8.81450024081687E-10 |
| N0-vs-N1 |
6.378600E-04 |
|
|
